ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
IL-18 inhibitor drug holds great potential for inflammatory diseases europeanpharmaceuticalreview
April 26, 2019An international team of researchers has identified the key role that IL-18 protein plays in Still’s disease, making it a prime candidate for IL-18 inhibitor drug that is proving promising in current trials. -
Sanofi signs $1bn drug development deal with Denali Therapeutics
pharmaceutical-technology
November 06, 2018Sanofi has entered a deal valued at more than $1bn with US-based Denali Therapeutics to advance potential drug candidates for the treatment of neurological and systemic inflammatory diseases.
Pharma Sources Insight July 2025
